THPO and Thrombocytopenia: The increased platelet clearance, along with increased platelet consumption, lung damage, dysfunctional bone marrow microenvironment, decreased thrombopoietin production, and antiviral drug use is the possible vital factor for thrombocytopenia COVID-19 cases [23].